Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cadherin 3 (CDH3), also known as P-cadherin, is a classical cadherin protein involved in calcium-dependent cell-cell adhesion. It plays an essential role in maintaining tissue architecture and is implicated in various cancers. Abnormal expression patterns make it an emerging target for cancer immunotherapies.
Emerging target for cancer immunotherapies; evaluation ongoing for its potential use against various carcinomas including those affecting lymph nodes via metastasis regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cadherin 3 (CDH3).